SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-015969
Filing Date
2017-08-07
Accepted
2017-08-07 16:02:25
Documents
48
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q derm-10q_20170630.htm 10-Q 1921924
2 EX-31.1 derm-ex311_9.htm EX-31.1 16924
3 EX-31.2 derm-ex312_8.htm EX-31.2 17577
4 EX-32.1 derm-ex321_7.htm EX-32.1 5762
5 EX-32.2 derm-ex322_6.htm EX-32.2 6418
  Complete submission text file 0001564590-17-015969.txt   5341290

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT derm-20170630.xml EX-101.INS 1082392
7 XBRL TAXONOMY EXTENSION SCHEMA derm-20170630.xsd EX-101.SCH 30448
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE derm-20170630_cal.xml EX-101.CAL 34367
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE derm-20170630_def.xml EX-101.DEF 95603
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE derm-20170630_lab.xml EX-101.LAB 253040
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE derm-20170630_pre.xml EX-101.PRE 190933
Mailing Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025
Business Address 275 MIDDLEFIELD ROAD SUITE 150 MENLO PARK CA 94025 650 421 7200
Dermira, Inc. (Filer) CIK: 0001557883 (see all company filings)

IRS No.: 273267680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36668 | Film No.: 171011477
SIC: 2834 Pharmaceutical Preparations